Big Purple Dragon (Cannabis flos PhytoPur Bio): lineage of Purple Urkle and Dragon’s Breath
Big Purple Dragon is a hybrid supplied to Polish pharmacies by one producer. We have gathered its lineage, terpene profile composition from the only source that describes it, and what studies on caryophyllene have not shown.
| Strain card | Big Purple Dragon |
|---|---|
| Producers | PhytoPur Bio (1 pharmacy position) |
| Medical brand | the same as the producer |
| Alternative names | none |
| Category according to sources | hybrid |
| Leading terpene | caryophyllene |
| Other terpenes | humulene linalool myrcene |
| Lineage | established Purple Urkle × Dragon’S Breath |
| Source consistency | one source |
- Who supplies it. Exclusively PhytoPur Bio, so there is nothing to compare versions with, and a supply break means the absence of this strain, not another version of it.
- Profile. It leads with caryophyllene, alongside humulene, linalool, and myrcene. We do not provide percentage shares because sources calculate them against different totals.
- Origin. The lineage is established, with parents being Purple Urkle and Dragon’S Breath.
- What is missing. The profile describes one source, so there is nothing to compare it with.
Where does Big Purple Dragon come from and what does its lineage say about it?
Big Purple Dragon is a hybrid created by crossing Purple Urkle with Dragon’s Breath. The lineage is provided by two independent strain descriptions, one of which directly refers to the pharmacy version from PhytoPur Bio. Both sources also agree on the type of plant, so the designation hybrid is not a guess here.
However, the lineage says less than the name would suggest. The crossbreeding record describes the origin of the seed material, not the chemical composition of the offspring: under the same parent combination, there are usually several lines selected separately by different breeders, each yielding different results in batch testing. Knowing the parents thus organizes the genealogy and nothing more.
The sources of this information must be named. Both lineage indications are market descriptions, one general and one directly referring to the PhytoPur Bio product, and not the drug registration documentation. In the documents allowing the dried flower to be marketed, the parent plant does not appear, as it is not a quality parameter of the raw material.
In the context of the entire set, this strain performs well. The origin has been established for 60 out of 85 described cultivars, while for the remaining 25, it is not available at all, as the breeder has never disclosed it or the available descriptions contradict each other. The declared THC content ranges from 21.6-26.4%, given as a range because the allowable deviation from the label value reaches one-tenth of the declaration, and each batch is tested separately.
Who supplies this strain to Polish pharmacies?
One supplier. In the compiled set, Big Purple Dragon appears exclusively in the version from PhytoPur Bio, so there is nothing to compare between producers: there is no second pharmacy version of the same name. The current availability status along with prices is in the collective strain summary, not here.
| Producer | What is known about the pharmacy version | How it differs from other versions |
|---|---|---|
| PhytoPur Bio | The only pharmacy version of this name in the compiled set; the dried flower is dispensed by prescription in the Rpw category | There is no second version to compare it with |
One supplier also means one cultivation path. With names run concurrently by two companies, it is possible to compare batch test results and see how the same genetics diverges in the hands of different producers. Here, such a comparison cannot be made, and the description prepared by the producer remains the only description of this strain available to Polish patients.
The list of suppliers is not permanent. The dried flower reaches pharmacies in batches, and a break in import or withdrawal of a series can remove the name from circulation for many weeks and restore it later, sometimes with a noticeably different test result. The record of one producer thus describes the moment when this compilation was created, not a permanent property of the strain.
Access to this item is determined by a prescription, not stock status. The cannabis flower is dispensed exclusively by prescription in the Rpw category. Other items from this producer are described separately, and the list of everything currently available in pharmacies is maintained in the collective strain summary.
What does Big Purple Dragon smell and taste like?
- humulene humulene
- caryophyllene caryophyllene (leading in the pharmacy list)
- linalool linalool
- myrcene myrcene
The smell of this strain has not been measured. What can be said comes from the profile composition provided by one source: caryophyllene, humulene, linalool, and myrcene. These molecules have recognizable notes, so the direction of the aroma can be described, but the specific smell of the batch remains a matter of olfaction.
Caryophyllene is the same molecule responsible for the sharp note of black pepper. It leads the profile, so the whole is often described as spicy, with a distinct woody background, closer to resinous heaviness than citrus brightness. Humulene, also present in hop cones, adds an earthy and slightly bitter tone.
Linalool brings a floral note known from lavender, while myrcene adds a herbal and slightly musky tone. The presence of these four molecules together explains why strain descriptions rarely hit on sweetness, although the name itself might suggest it.
This description has a clear boundary. Neither the smell nor the taste of this strain has been studied under controlled conditions, and what one person feels depends on the vaporizer temperature, the moisture of the dried flower, and their own sensitivity threshold. The aroma does not predict the effect either: the connection between smell and effect is a guess, not a determination.
How long does it take for the effect to appear and how long does it last?
The route of administration determines this, not the strain name. When inhaling vapor, the effect builds up within a few minutes and ends the same day; when swallowed, it starts with a noticeable delay and lasts much longer. The time frames given below refer to the physiology of absorption, not this specific cultivar.
The route of administration determines the course more than the strain itself, and the ranges below describe it, not this cultivar, as pharmacokinetic studies for a single cultivar have not been published.
| Vaporization | After swallowing | |
|---|---|---|
| First sensations | after a few minutes | from half an hour to two |
| Build-up | another dozen to thirty minutes | slow, over several hours |
| Total duration | within two to four hours | after six, sometimes eight hours |
| Typical mistake | none | taking a dose after thirty minutes, which gives both doses at once |
For Big Purple Dragon itself, there is no such measurement, and one should not expect it. Pharmacokinetic studies are conducted for preparations with established, repeatable compositions, not for commercial names of dried flowers, whose test results change between batches.
What has been studied in relation to this strain, and what has not?
The strain itself has not been studied. Published works concern caryophyllene, a single molecule present in its profile, and were conducted on mice and in vitro. Everything that goes beyond this comes from patient reports or sales materials and does not have the status of evidence.
| Study | Model and route of administration | What was shown |
|---|---|---|
| Gertsch J et al., 2008 Proceedings of the National Academy of Sciences (PNAS) PMID:18574142 |
mouse (in vivo) and in vitro (receptor binding, human cells) | (E)-caryophyllene selectively bound to the CB2 receptor (Ki = 155 nM) and inhibited carrageenan-induced paw swelling in wild-type mice, but not in CB2 receptor knockout mice (Cnr2-/-), indicating a CB2-dependent mechanism; the study did not include any anxiety tests. |
| Klauke AL et al., 2014 European Neuropsychopharmacology PMID:24210682 |
rodent (mouse) | Oral caryophyllene reduced late inflammatory pain in mice in the formalin test in a CB2 receptor-dependent manner, with no effect on the early phase; in a neuropathic pain model, it alleviated thermal hyperalgesia and mechanical allodynia without developing tolerance with chronic administration. |
In neither of the two studies was caryophyllene tested on humans or in inhaled form from dried flower; both works concern oral or systemic administration in mice in pain and inflammation models, not sleep or mood.
The rest of what is said about this strain is not evidence. Descriptions of effects circulating on forums and in sales materials are reports from individual people, collected without a control group and without blinding, so it is impossible to separate the effect of the raw material from expectations towards it.
The profile composition is known from one database, budcare.pl, which lists alongside caryophyllene humulene, linalool, and myrcene.
We do not provide percentage shares. The sums of shares published by Polish databases for the same items vary from 46 to 73 to 83 percent, so the denominator is different in each compilation, and the numbers from the two tables cannot be compared.
What side effects are reported from this type of dried flower?
There are no separate reports for this name. Big Purple Dragon is supplied by one company, and even with more widely available cultivars, no compilations of symptoms are created broken down by strain. The description below therefore pertains to cannabis flower as a group of raw materials and is common to all items in this compilation.
Reports of adverse effects are collected for a medicinal product with a batch number, not for a strain name, so the following pertains to cannabis flower as a group of raw materials. The most common symptoms are dry mouth, red eyes, and increased heart rate. Less frequently reported are dizziness upon rapid standing, daytime drowsiness, and transient worsening of short-term memory, as well as anxiety that increases with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for cannabis flower in Poland do not separate them by individual products.
The assessment of whether this dried flower can be reconciled with the rest of the treatment is up to the prescribing physician and the pharmacist, as it requires insight into the full list of preparations being taken, not just the description of the plant.
At what temperature should this dried flower be vaporized?
There is no single correct value. Caryophyllene, the leading molecule in this profile, evaporates at a higher range than lighter terpenes, so low settings will leave it in the dried flower. However, temperature tables often contradict each other and measure something different than what happens in the chamber.
The number on the display is not the temperature of the dried flower. The heater measures itself or the air right next to it, and the material in the chamber can be cooler by several dozen degrees, depending on the device’s construction, the packing of the chamber, and the rate of inhalation. The same setting on two vaporizers does not mean the same state of the raw material.
Temperature tables for terpene evaporation also contradict each other. Published values come from measurements taken at different pressures and for pure substances, not for a mixture settled on plant material, so transferring them directly to the device setting is an oversimplification. The scale of these discrepancies is described separately.
A practical conclusion for this profile is to be cautious. Lighter molecules are released earlier, and they build the first draw, while caryophyllene along with humulene evaporates later, so setting at the lower end of the scale impoverishes the aroma of that part of the profile. How these thresholds are distributed is shown in the context of terpene evaporation.
Does Big Purple Dragon have siblings available in Polish pharmacies?
No. In the lineage graph of this compilation, no other cultivar available in Polish pharmacies shares both parents with it or even one identified parent. An empty list is not a data gap but a result: Purple Urkle and Dragon’s Breath do not appear in the lineages of the other described strains.
An empty sibling list can also be a correct result even with a known lineage. The field for related strains has content in 29 out of 85 cultivars, while the rest remains empty, partly because a parent can be a landrace or a broad family style, such as afghani or haze. These are categories, not single, identified strains, so two cultivars having only such an ancestor in common do not become siblings because of that.
There is also no association by name. A common element with another strain does not prove anything in either direction: in this compilation, the word kush carries ten cultivars, of which five have an established lineage, and five do not have it at all. Big Purple Dragon shares a name element with several other market positions, and that also says nothing about kinship.
However, strains with a similar profile composition can be found differently, through the leading terpene. The compilation of cultivars where caryophyllene leads is described separately, and the full list of items present in Polish pharmacies is maintained in the collective strain summary.
Frequently asked questions about Big Purple Dragon
Is Big Purple Dragon available in Polish pharmacies?
Yes, in the compiled set, it is supplied by one company, PhytoPur Bio. The cannabis flower is dispensed exclusively by prescription in the Rpw category, and the availability of individual items changes with deliveries, so the current status is checked in the collective strain summary, not in the strain description.
Which terpene leads in the profile of this strain?
Caryophyllene. The profile composition is provided by one database, budcare.pl, listing alongside it humulene, linalool, and myrcene. We do not provide percentage shares, as sources do not disclose the denominator against which they calculate them.
What is the THC content in Big Purple Dragon?
The declared content ranges from 21.6-26.4%. We provide it as a range, not a single number, because the allowable deviation from the label value reaches one-tenth of the declaration, and each batch of dried flower is tested separately.
Is Big Purple Dragon an indica or sativa?
Available descriptions consistently classify it as a hybrid. The division into indica and sativa primarily refers to the plant’s growth habit and its geographical origin, not how the dried flower will affect a specific patient.
Has it been shown that this strain has analgesic effects?
No. Two studies that can be referenced here concern caryophyllene administered to mice, not this strain or the dried flower in inhaled form. Transferring their results to humans would be an overinterpretation, not a conclusion.
Does Big Purple Dragon have siblings among pharmacy strains?
No. No other cultivar described in this compilation shares an identified parent with it, so the field for related strains remains empty. This is not a lack of data but a result of searching the lineage graph.
The cannabis flower is a pharmaceutical raw material dispensed by prescription in the Rpw category. The above text is for informational purposes, describes the state of available data, and does not replace medical or pharmaceutical advice.
Author: ubucha
